The efficacy of ppI After endoscopic Hemostasis in patients with Bleeding Peptic Ulcer and Role of Helicobacter Pylori
Zaim Gashi, Nenad Joksimovic, Gani Dragusha, Aurora Bakalli
Med Arh. 2012; 66(4): 236-239
Background: Nowadays PPI present cornerstone in the medical therapy of bleeding peptic ulcer. Controlled pantoprazole data in peptic ulcer bleeding are few. Aim: To compare the effect of intravenous (iv) pantoprazole (PPI) with iv ranitidine (H2RA) for bleeding peptic ulcers after endoscopic therapy. Methods: After endoscopic haemostasis, 122 patients were randomized to PPI 80 mg + 8mg/h or H2RA 50 mg + 13mg/h, both for 72 h and to continue with oral equivalent dose of these medicaments. Patients underwent second-look endoscopy on day 3 or earlier, if clinically indicated. The primary endpoint measure was re-bleeding before discharge and <14 days of enrollment. Secondary endpoint measures included number of surgeries performed, volume of blood transfusion, mortality rate and hospital stay. All data were statistically analyzed and a value of 0.05 or less was considered to indicate statistical significance. Results: In the group who were treated with PPI, re-bleeding rate was evidenced in 5 patients (8.33%) and in the groups who were treated with H2RA, re-bleeding rate was found in 9 patients (14.5%) with RR 0.27 and CI 0.12-0.60 and P< 0.05. The volume of transfused blood was lower in the group treated with PPI compared to the group treated with H2RA (930 ml vs. 1540 ml and P< 0.05). In this study there was not statistically significant difference in the hospital stay 15.00 vs. 17.80% (9 vs. 11 patients and P> 0.05), the need for surgical intervention 5.00 vs. 6.45% (3 vs. 4 patients and P= 1.00 ) and the mortality rate 1.66 vs. 3.22% (1 vs. 2 patients and P> 0.05).Conclusion: A high-dose pantoprazole infusion is more effective than a ranitidine infusion for prevention of re-bleeding after endoscopic epinephrine injection in patients with peptic ulcers and active bleeding or non-bleeding visible vessels (P<0.05). In all bleeding peptic ulcer patients is needed to make the eradication of H. pylori infection with the aim to prevent re-bleeding in long term.
1. Labenz J. et al. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomized controlled study. Gut 1997;40:36-41.
2. Leontiadis GI et al. Proton pump inhibitor treatment for acute peptic ulcer bleeding. The Cochrane Database of Systematic Reviews 2006;1:CD002094.
3. Lee KK et al. Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointest Endosc 2003;57:160-164.
4. Laine L, Peterson WL. Bleeding peptic ulcer. N Eng J Med. 1994; 331:717-27.
5. Barkun AN et al. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding. Aliment Pharmacol Ther 2004;20:195-202.
6. Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM. Proton pump inhibitors versus H2 antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther 2001, 15(7):917-26.
7. Collins R, Langman M. Treatment with Histamine H2 antagonists in upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl JMed 1985;313:660.
8. Levine J et al. Meta-analysis: The efficacy of H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002 Jun; 16:1 137-42.
9. Lau JY, Sung JJ, Lee KK et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleedeing peptic ulcers. N Engl J Med Aug 3 2000:343:310-16.
10. Fried R, Begliner C, Meier R, Stumpf J, Adier G, Schepp W, Klein M, Fischer R. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding . Gut 1999 Suppl V;(45):P0104.
11. Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. High dose intravenouis proton pump inhibiton following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada; a cost-effectiveness analysis. Aliment Pharmacol Ther. 2004: 19(5):591-600 (ISSN 0269-2813).
12. Martin JE, Macaulay SS, Zarnke KB, et al. Proton Pump Inhibitors versus H2 antagonists or placebo for upper gastrointestinal bleeding with or without endoscopic hemostasis: a meta-analysis. Gastroenterology, 2003; 124 (Suppl.1): A625.
13. Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay-results from the Cochrane Collaboration, Aliment Pharmacol Ther, 2005; 22:169-74.